Banca de QUALIFICAÇÃO: CARLOS EDUARDO SEVERO DO VALE

Uma banca de QUALIFICAÇÃO de MESTRADO foi cadastrada pelo programa.
STUDENT : CARLOS EDUARDO SEVERO DO VALE
DATE: 25/11/2026
TIME: 11:00
LOCAL: VIDEOCONFERÊNCIA
TITLE:

Prospecting the antithrombotic potential of medicinal plants: scoping review and evaluation of the plant species Jatropha gossypiifolia L.


KEY WORDS:

Jatropha gossypiifolia; Scoping review; Hemostasis; Anticoagulant activity; Platelet aggregation; Medicinal plants.


PAGES: 255
BIG AREA: Ciências da Saúde
AREA: Farmácia
SUMMARY:

Antithrombotic agents are essential for preventing and treating cardiovascular diseases, but their use is limited by bleeding risk, drug interactions, and variability in response. These limitations encourage the investigation of medicinal plants as sources of new therapeutic agents, given their chemical diversity. This study aimed to map the evidence on the antithrombotic potential of medicinal plants and their derivatives and to evaluate, in vitro, the effects of the extract and phenolic-enriched ethanolic fraction of Jatropha gossypiifolia L. on coagulation and platelet aggregation. The scoping review was registered on the Open Science Framework and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). Original peer-reviewed studies investigating activities related to thrombosis and hemostasis were retrieved from PubMed, Scopus, Web of Science, and Embase, without language or publication-year restrictions. Reviews, exclusively ethnopharmacological studies, combinations of plants, and combinations of plant products with drugs were excluded. The synthesis included 720 articles, 849 species, and 152 families. Crude extracts accounted for 63.0% of the recorded plant derivatives. Among records assessing pharmacological activity related to hemostasis, 39.9% addressed antiplatelet activity, while in vitro assays accounted for 80.2% of all recorded experimental approaches. Only ten clinical articles evaluated foods, oils, and extracts in healthy participants or individuals with cardiovascular risk factors, with no trial phases reported in the consulted sources. Approximately 75% of species were investigated in a single study, indicating broad botanical diversity but limited evidence per species, which restricts the robustness and consolidation of the evidence. Bleeding was assessed for only 6.8% of all recorded derivatives and 10.4% of all recorded species, revealing a gap in the joint assessment of activity and bleeding risk. Thus, the scoping review showed that the diversity of investigated medicinal plants and derivatives has yet to translate into sufficient evidence of antithrombotic efficacy and safety for therapeutic use, given the predominance of in vitro assays, limited investigation per species, and scarcity of clinical and bleeding assessments. In the experimental stage, the 70% hydroethanolic extract and the ethanolic fraction obtained using XAD-4 resin were evaluated by light transmission aggregometry, prothrombin time (PT), and activated partial thromboplastin time (aPTT). Following standardization of the aggregometry assay, neither preparation significantly reduced maximal aggregation induced by 10 µM adenosine diphosphate (ADP) at concentrations ranging from 0.3125 to 10 µg/mL. The color of the extract restricted the concentration range compatible with optical measurements. In coagulation assays conducted at concentrations ranging from 500 to 1,750 µg/µL, both preparations significantly prolonged aPTT at 1,250, 1,500, and 1,750 µg/µL. The extract also prolonged PT at 1,750 µg/µL, whereas the fraction did not significantly alter this parameter at any concentration tested. The experimental findings indicated in vitro anticoagulant potential. Further studies are needed to establish antithrombotic activity, determine whether the observed effects are reproduced in in vivo models, and assess whether antithrombotic activity occurs at doses that neither increase bleeding nor cause toxicity.


COMMITTEE MEMBERS:
Externa ao Programa - 3075402 - DEYSE DE SOUZA DANTAS - nullExterna ao Programa - 3551691 - JACINTHIA BEATRIZ XAVIER DOS SANTOS - nullPresidente - 1055045 - MARCELA ABBOTT GALVAO URURAHY
Notícia cadastrada em: 05/11/2026 11:00
SIGAA | Superintendência de Tecnologia da Informação - (84) 3342 2210 | Copyright © 2006-2026 - UFRN - sigaa09-producao.info.ufrn.br.sigaa09-producao